|
Dec 12
|
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
|
|
Dec 7
|
Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report?
|
|
Nov 8
|
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Why Iovance Biotherapeutics Stock Is Marching Higher Today
|
|
Nov 8
|
Iovance's (IOVA) Meets Q3 Earnings, Lags Sales Estimates
|
|
Nov 7
|
Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates
|
|
Oct 16
|
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress
|
|
Sep 7
|
Why Is Iovance Biotherapeutics (IOVA) Down 21.2% Since Last Earnings Report?
|
|
Sep 7
|
Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
|
|
Jul 21
|
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|
|
Apr 24
|
Iovance Biotherapeutics to Present at Upcoming Conferences
|